New TB tools need to be affordable in the private sector: The case study of Xpert MTB/RIF

A new 13-country patient pathway analysis published in the Journal of Epidemiology and Global Health presents updated data on what patients pay for Xpert MTB/RIF testing in the private health sector in highly privatized health markets.